NICE accreditation
We work with guidance producers looking to renew their existing accreditation. The programme no longer accepts new applications.
The accreditation programme assesses the processes used to produce guidance and advice. This will, in turn, help raise standards in guidance production. Please continue to use the facilities on NICE Evidence Search to search for accredited guidance.
Go to NICE Evidence Search- To help health and social care professionals identify the most trusted sources of guidance developed using critically evaluated
high quality processes - To drive up the quality of information used by health and social care professionals in decision making
- To improve patient outcomes through providing robust evidence for NICE quality standards
- Increase the visibility of guidance and advice
- Attain accreditation for guidance making it eligible to be considered for the development of NICE quality standards
- Promote guideline development processes as being robust and transparent
- Use the NICE Accreditation Mark as an indication of high standard, good quality information
Eligibility
Guidance producers that meet our definition of guidance and advice, as detailed in the Accreditation process manual, may apply for accreditation.
Readiness to apply
Steps providing a brief summary of the NICE accreditation process for guidance producers.
Application
Required information and notes on completing the accreditation application form.
Recent accreditations
Royal Pharmaceutical Society
NICE has accredited the process used by Royal Pharmaceutical Society to produce its professional guidance and standards. Accreditation is valid for 5 years from 17 February 2017 and is retrospectively applicable to guidance produced using the processes described in ‘Professional standards, guidance and frameworks, process development manual’ (2016).
The Midlands Therapeutics Review and Advisory Committee (MTRAC )
NICE has accredited the process used by the Midlands Therapeutics Review and Advisory Committee to produce Commissioning support summaries. Accreditation is valid for 5 years from 7 March 2017 and is retrospectively applicable to guidance produced using the processes described in the MTRAC Handbook (2017).
British Transplantation Society
NICE has renewed accreditation of the process used by the British Transplantation Society to produce clinical guidelines. The renewed accreditation is valid until 25 January 2022 and applies to guidance produced using the processes described in BTS Guideline Development Policy, Revised: 14 January 2016. The original accreditation term began on 25 January 2012.
Regional Drug and Therapeutics Centre
NICE has accredited the process used by the Regional Drug and Therapeutics Centre to produce New Drug Evaluations. Accreditation is valid for 5 years from 7 March 2017 and is retrospectively applicable to guidance produced using the processes described in New Drug Evaluations Process Manual v.3.0 (October 2016).
British Association of Dermatologists
NICE has accredited the process used by the British Association of Dermatologists to produce Service Guidance and Standards. Accreditation is valid for 5 years from 7 March 2017 and is retrospectively applicable to guidance produced using the processes described in Developing Dermatology Service Guidance, 2016.
National Osteoporosis Guideline Group
NICE has accredited the process used by the National Osteoporosis Guideline Group to produce
Children’s Brain Tumour Research Centre
NICE has renewed accreditation of the process used by the Children’s Brain Tumour Research Centre to produce The brain pathways guideline. The renewed accreditation is valid until 21 July 2021 and applies to guidance produced using the processes described in ‘The brain pathways guideline’ (2016). The original accreditation term began on 21 July 2011.